BUSINESSSEMAFOR
Kalshi bets on Wall Street
Kalshi expanded its presence on Wall Street by launching 13 new contracts for betting on biotech drug trial outcomes and expanding contracts tracking AI compute costs. The platform also introduced a Bloomberg terminal-like tool and emphasized institutional financial market integration, including efforts to combat insider trading.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals
- Exclusive: Prediction market startup Pascal raises $9 million to challenge heavyweights Kalshi and Polymarket
- Kalshi is trying to turn flight cancellations into trades
- Robinhood allows users to use AI agents to trade stocks